Trial Profile
A phase I/II study of Bicizar (C1-esterase inhibitor) in sepsis patients
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 27 Nov 2015
Price :
$35
*
At a glance
- Drugs Complement C1 inhibitor protein (Primary)
- Indications Sepsis
- Focus Therapeutic Use
- 27 Nov 2015 New trial record
- 29 Nov 2006 According to Biogenius media release, the MOH state regulators of Russia approved to conduct this trial.